<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00566709</url>
  </required_header>
  <id_info>
    <org_study_id>PI-0157/2006</org_study_id>
    <secondary_id>PI 157/06</secondary_id>
    <nct_id>NCT00566709</nct_id>
  </id_info>
  <brief_title>Near Infrared Spectroscopy (NIRS) as Transfusion Indicator in Neurocritical Patients</brief_title>
  <official_title>Phase II Study of Usefulness of Near Infrared Spectroscopy to Optimize Red Blood Cells Transfusion in Neuro Critical Ill Patients With Severe Traumatic Brain Injury, Subarachnoid Hemorrhage or Intracerebral Hemorrhage.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospitales Universitarios Virgen del Rocío</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospitales Universitarios Virgen del Rocío</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Neurocritical ill patients are frequently transfused. Red blood cell transfusion (RBCT) in
      these patients has been associated with deleterious effects, including higher rates of
      nosocomial infections, multi-organ failure, and mortality. Therefore, it seems crucial to
      avoid any unnecessary RBCT.

      Most critically ill patients tolerate hemoglobin levels near 7 g/dL without an increase in
      morbidity or mortality rates. In this regard, a recent sub-analysis of TRICC trial has showed
      that TBI patients may tolerate hemoglobin levels as low as 7 g/dL, but other studies
      including neurocritical patients suggested that severe anemia may worsen clinical outcome.
      Therefore, optimal hemoglobin levels in neurocritical care patients remain largely unknown.
      Some textbooks and guidelines recommend to transfuse these patients to reach hemoglobin
      levels near to 10 g/dL, despite the lack of a solid scientific background supporting this
      target.

      Even though it has not been demonstrated, hemoglobin-based RBCT prescription could result in
      over- or under-transfusion in neurocritical patients. Alternatively, it has been suggested
      that more physiological transfusion triggers, using direct signals coming from the brain,
      will progressively replace arbitrary hemoglobin-based transfusion triggers in the
      neurocritical patients [65]. At the neurocritical units, patients are often monitored by
      using non-invasive methods, such as near infrared spectroscopy which indirectly measures
      regional cerebral oxygen saturation (rSO2). Changes in rSO2 values have been shown to
      directly correlate with changes in erythrocyte mass, thus increasing with RBCT and decreasing
      with blood losses. Moreover, rSO2 values also show a good correlation with clinical outcome
      and other variables which are often monitored in TBI patients.

      The purpose of this study is to ascertain as to whether rSO2 levels are more efficacious than
      conventional hemoglobin levels in guiding RBCT in patients admitted to a neurocritical care
      unit.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2009</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">November 2009</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Units of Packed Red Blood Cell Transfused</measure>
    <time_frame>duration of the protocol, an average of 15 days</time_frame>
    <description>Number of units of packed packed red blood cell transfused, over the period that the patient was included into the protocol</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Transfused Patients in Each Group</measure>
    <time_frame>duration of the protocol, an average of 15 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hospital Mortality</measure>
    <time_frame>length of the hospital stay, an average of 20 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Intensive Care Unit (ICU) Stay</measure>
    <time_frame>The length of ICU stay, an avarege of 17 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Long-term Mortality</measure>
    <time_frame>1-year after hospital discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Unfavorable Glasgow Outcome Scale (GOS)</measure>
    <time_frame>At hospital discharge, an average of 21 days</time_frame>
    <description>GOS measures the degree of disability associated with the brain injury
Unfavorable GOS included the categories of:
death.
vegetative status.
severe disability.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">102</enrollment>
  <condition>Traumatic Brain Injury</condition>
  <condition>Subarachnoid Hemorrhage</condition>
  <condition>Intracerebral Hemorrhage</condition>
  <arm_group>
    <arm_group_label>RBCT based on rSO2 value</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention: In the rSO2 - strategy group, patients will be transfused to attain a post-transfusion rSO2 values higher than 60%.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RBCT based on hemoglobin level value</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intervention: In the hemoglobin - strategy group, patients will be transfused to reach post-transfusion hemoglobin levels between 8.5 g/dL and 10 g/dL.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Red blood cells transfusion</intervention_name>
    <description>Patients will be transfused (one to one red blood cells unit transfusion)</description>
    <arm_group_label>RBCT based on rSO2 value</arm_group_label>
    <arm_group_label>RBCT based on hemoglobin level value</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Severe traumatic brain injury (Glasgow coma scale &lt; 9), subarachnoid hemorrhage (Hunt
             and Hess scale ≥ 3) or intracranial hemorrhage

          -  Moderate anemia. Hemoglobin levels &gt; 7 g/dL and &lt; 10 g/dL

          -  Hemodynamical stability (mean arterial pressure &gt; 75 mm Hg)

          -  Respiratory stability (PaO2 / FiO2 ratio &gt; 220)

          -  Expected length of ICU stay &gt; 3 days

        Exclusion Criteria:

          -  Patient's relatives' refusal to patient's inclusion in the study

          -  Active bleeding

          -  Ongoing need for blood products

          -  Patients necessitating ongoing resuscitation

          -  End-stage in which death is imminent

          -  Antecedents of angina or myocardial infarction (poor cardiopulmonary reserve)

          -  Deficient signal of rSO2 impeding its proper valuation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Santiago R Leal-Noval, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario &quot;Virgen del Rocío&quot;, Seville, Spain</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Victoria Arellano, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital Universitario &quot;Virgen del Rocío&quot;, Seville, Spain</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rosario Amaya, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital Universitario &quot;Virgen del Rocío&quot;, Seville, Spain</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antonio M Puppo, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital Universitario &quot;Virgen del Rocío&quot;, Seville, Spain</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Carmen M Ferrándiz, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital Universitario &quot;Virgen del Rocío&quot;, Seville, Spain</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antonio J Marín, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital Universitario &quot;Virgen del Rocío&quot;, Seville, Spain</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Francisco Murillo, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Hospital Universitario &quot;Virgen del Rocío&quot;, Seville, Spain</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Manuel Muñoz, Prof, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Prof Transfusion Medicine University of Malaga, Spain</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Vicente Padilla, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Hospitales Universitarios Virgen del Rocío</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yael Corcia, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Hospitales Universitarios Virgen del Rocío</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Aurelio Cayuela, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital Universitario &quot;Virgen del Rocio&quot;</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Universitario &quot;Virgen del Rocío&quot;</name>
      <address>
        <city>Seville</city>
        <zip>41013</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 29, 2007</study_first_submitted>
  <study_first_submitted_qc>November 30, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 3, 2007</study_first_posted>
  <results_first_submitted>November 20, 2015</results_first_submitted>
  <results_first_submitted_qc>February 12, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">March 11, 2016</results_first_posted>
  <last_update_submitted>March 21, 2016</last_update_submitted>
  <last_update_submitted_qc>March 21, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 19, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospitales Universitarios Virgen del Rocío</investigator_affiliation>
    <investigator_full_name>Santiago R. Leal-Noval</investigator_full_name>
    <investigator_title>Santiago R. Leal-Noval, MD Ph.D</investigator_title>
  </responsible_party>
  <keyword>transfusion</keyword>
  <keyword>NIRS</keyword>
  <keyword>cerebral oxygenation</keyword>
  <keyword>red blood cell</keyword>
  <keyword>near infrared spectroscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Brain Injuries, Traumatic</mesh_term>
    <mesh_term>Subarachnoid Hemorrhage</mesh_term>
    <mesh_term>Cerebral Hemorrhage</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>RBCT Based on rSO2 Value</title>
          <description>Intervention: In the rSO2 - strategy group, patients will be transfused to attain a post-transfusion rSO2 values higher than 60%.
Red blood cells transfusion: Patients will be transfused (one to one red blood cells unit transfusion)</description>
        </group>
        <group group_id="P2">
          <title>RBCT Based on Hemoglobin Level Value</title>
          <description>Intervention: In the hemoglobin – strategy group, patients will be transfused to reach post-transfusion hemoglobin levels between 8.5 g/dL and 10 g/dL.
Red blood cells transfusion: Patients will be transfused (one to one red blood cells unit transfusion)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="51"/>
                <participants group_id="P2" count="51"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="46"/>
                <participants group_id="P2" count="51"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Patient included into to &quot;Intention to treat&quot; analysis</population>
      <group_list>
        <group group_id="B1">
          <title>RBCT Based on rSO2 Value</title>
          <description>Intervention: In the rSO2 - strategy group, patients will be transfused to attain a post-transfusion rSO2 values higher than 60%.
Red blood cells transfusion: Patients will be transfused (one to one red blood cells unit transfusion)</description>
        </group>
        <group group_id="B2">
          <title>RBCT Based on Hemoglobin Level Value</title>
          <description>Intervention: In the hemoglobin – strategy group, patients will be transfused to reach post-transfusion hemoglobin levels between 8.5 g/dL and 10 g/dL.
Red blood cells transfusion: Patients will be transfused (one to one red blood cells unit transfusion)</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="51"/>
            <count group_id="B2" value="51"/>
            <count group_id="B3" value="102"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45.2" spread="18.3"/>
                    <measurement group_id="B2" value="46.1" spread="16.3"/>
                    <measurement group_id="B3" value="45.6" spread="17.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                    <measurement group_id="B2" value="31"/>
                    <measurement group_id="B3" value="66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Hemoglobin (g/L)</title>
          <units>g/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="110.9" spread="21.2"/>
                    <measurement group_id="B2" value="114" spread="21.6"/>
                    <measurement group_id="B3" value="112.4" spread="21.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Arterial Hypertension (n)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37"/>
                    <measurement group_id="B2" value="36"/>
                    <measurement group_id="B3" value="73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Diabetes mellitus (n)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="49"/>
                    <measurement group_id="B2" value="46"/>
                    <measurement group_id="B3" value="95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>APACHE II score</title>
          <description>Acute Physiology and Chronic Health Evaluation (APACHE) II score Minimun score:0, Maximum score: 71 Higher values represent worse result.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14.6" spread="4.8"/>
                    <measurement group_id="B2" value="13.8" spread="4.2"/>
                    <measurement group_id="B3" value="14.1" spread="4.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>GCS</title>
          <description>Glasgow Coma Scale Minimun: 3; Maximum: 15 Higher values represent better outcome</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9" lower_limit="7" upper_limit="12"/>
                    <measurement group_id="B2" value="9" lower_limit="7" upper_limit="11"/>
                    <measurement group_id="B3" value="9" lower_limit="7" upper_limit="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>ISS score (N=30, 27)</title>
          <description>Injury severity score (ISS) Minimum: 0; maximum: 75 Higher values represent worse outcome
ISS is only collected in patients with traumatic brain injury (N=57)
30 into rSO2 arm
27 into hemoglobin arm</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28.0" spread="9.8"/>
                    <measurement group_id="B2" value="29.0" spread="9.6"/>
                    <measurement group_id="B3" value="28.5" spread="9.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Hunt and Hess scale (N=10, 13)</title>
          <description>Hunt and Hess scale for assessing the severity of patients with subarachnoid hemorrhage Minimum: 1; Maximum: 5 Higher values represent worse outcome
Only 23 patients with subarachnoid hemorrhage are included.
10 into rSO2 arm
13 into hemoglobin arm</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4.1" spread="1.2"/>
                    <measurement group_id="B2" value="4.1" spread="0.8"/>
                    <measurement group_id="B3" value="4.1" spread="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Fisher scale (N=10, 13)</title>
          <description>Computer tomography Fisher Scale
Minimum: 1; Maximum: 4
Higher values represent worse outcome
Only 23 patients with subarachnoid hemorrhage are included
10 into rSO2 arm
13 into hemoglobin arm</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3.9" spread="0.3"/>
                    <measurement group_id="B2" value="3.8" spread="0.4"/>
                    <measurement group_id="B3" value="3.8" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Modified Grab score (N=11, 11)</title>
          <description>Modified Graeb score for intra cerebral hemorrhage Minimum: 0; maximum: 42.
Higher values represent worse outcome
Only 22 patients with intra cerebral hemorrhage are included
11 into rSO2 arm.
11 into hemoglobin arm.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6.7" spread="3.9"/>
                    <measurement group_id="B2" value="5.9" spread="3"/>
                    <measurement group_id="B3" value="6.3" spread="3.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>PbrO2 (mm Hg) (N=17, 22)</title>
          <description>Pressure brain regional oxygen: PbrO2
Only 39 patients monitored with a PbrO2 probe are included:
17 into rSO2 arm
22 into hemoglobin arm</description>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21.9" spread="5.7"/>
                    <measurement group_id="B2" value="22.8" spread="5.6"/>
                    <measurement group_id="B3" value="22.4" spread="5.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>CPP (mm Hg) (N=17, 22)</title>
          <description>Cerebral perfusion pressure (CPP)
Only 39 patients monitored with a PbrO2 probe are included:
17 into rSO2 arm
22 into hemoglobin arm</description>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="73.9" spread="18.5"/>
                    <measurement group_id="B2" value="72.9" spread="15.6"/>
                    <measurement group_id="B3" value="73.4" spread="16.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Diagnosis</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Traumatic Brain Injury</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Subarachnoid hemorrhage</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Intra cerebral hemorrhage</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Units of Packed Red Blood Cell Transfused</title>
        <description>Number of units of packed packed red blood cell transfused, over the period that the patient was included into the protocol</description>
        <time_frame>duration of the protocol, an average of 15 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>RBCT Based on rSO2 Value</title>
            <description>Intervention: In the rSO2 - strategy group, patients will be transfused to attain a post-transfusion rSO2 values higher than 60%.
Red blood cells transfusion: Patients will be transfused (one to one red blood cells unit transfusion)</description>
          </group>
          <group group_id="O2">
            <title>RBCT Based on Hemoglobin Level Value</title>
            <description>Intervention: In the hemoglobin – strategy group, patients will be transfused to reach post-transfusion hemoglobin levels between 8.5 g/dL and 10 g/dL.
Red blood cells transfusion: Patients will be transfused (one to one red blood cells unit transfusion)</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Units of Packed Red Blood Cell Transfused</title>
          <description>Number of units of packed packed red blood cell transfused, over the period that the patient was included into the protocol</description>
          <units>units</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="51"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.9" spread="1.1"/>
                    <measurement group_id="O2" value="1.5" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.03</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Transfused Patients in Each Group</title>
        <time_frame>duration of the protocol, an average of 15 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>RBCT Based on rSO2 Value</title>
            <description>Intervention: In the rSO2 - strategy group, patients will be transfused to attain a post-transfusion rSO2 values higher than 60%.
Red blood cells transfusion: Patients will be transfused (one to one red blood cells unit transfusion)</description>
          </group>
          <group group_id="O2">
            <title>RBCT Based on Hemoglobin Level Value</title>
            <description>Intervention: In the hemoglobin – strategy group, patients will be transfused to reach post-transfusion hemoglobin levels between 8.5 g/dL and 10 g/dL.
Red blood cells transfusion: Patients will be transfused (one to one red blood cells unit transfusion)</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Transfused Patients in Each Group</title>
          <units>percentage of transfused participant</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="51"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.3"/>
                    <measurement group_id="O2" value="70.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.07</p_value>
            <method>Chi-squared, Corrected</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hospital Mortality</title>
        <time_frame>length of the hospital stay, an average of 20 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>RBCT Based on rSO2 Value</title>
            <description>Intervention: In the rSO2 - strategy group, patients will be transfused to attain a post-transfusion rSO2 values higher than 60%.
Red blood cells transfusion: Patients will be transfused (one to one red blood cells unit transfusion)</description>
          </group>
          <group group_id="O2">
            <title>RBCT Based on Hemoglobin Level Value</title>
            <description>Intervention: In the hemoglobin – strategy group, patients will be transfused to reach post-transfusion hemoglobin levels between 8.5 g/dL and 10 g/dL.
Red blood cells transfusion: Patients will be transfused (one to one red blood cells unit transfusion)</description>
          </group>
        </group_list>
        <measure>
          <title>Hospital Mortality</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="51"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.56</p_value>
            <method>Chi-squared, Corrected</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Intensive Care Unit (ICU) Stay</title>
        <time_frame>The length of ICU stay, an avarege of 17 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>RBCT Based on rSO2 Value</title>
            <description>Intervention: In the rSO2 - strategy group, patients will be transfused to attain a post-transfusion rSO2 values higher than 60%.
Red blood cells transfusion: Patients will be transfused (one to one red blood cells unit transfusion)</description>
          </group>
          <group group_id="O2">
            <title>RBCT Based on Hemoglobin Level Value</title>
            <description>Intervention: In the hemoglobin – strategy group, patients will be transfused to reach post-transfusion hemoglobin levels between 8.5 g/dL and 10 g/dL.
Red blood cells transfusion: Patients will be transfused (one to one red blood cells unit transfusion)</description>
          </group>
        </group_list>
        <measure>
          <title>Length of Intensive Care Unit (ICU) Stay</title>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="51"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.00" spread="10.23"/>
                    <measurement group_id="O2" value="20.41" spread="11.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.79</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Long-term Mortality</title>
        <time_frame>1-year after hospital discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>RBCT Based on rSO2 Value</title>
            <description>Intervention: In the rSO2 - strategy group, patients will be transfused to attain a post-transfusion rSO2 values higher than 60%.
Red blood cells transfusion: Patients will be transfused (one to one red blood cells unit transfusion)</description>
          </group>
          <group group_id="O2">
            <title>RBCT Based on Hemoglobin Level Value</title>
            <description>Intervention: In the hemoglobin – strategy group, patients will be transfused to reach post-transfusion hemoglobin levels between 8.5 g/dL and 10 g/dL.
Red blood cells transfusion: Patients will be transfused (one to one red blood cells unit transfusion)</description>
          </group>
        </group_list>
        <measure>
          <title>Long-term Mortality</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="51"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.77</p_value>
            <method>Chi-squared, Corrected</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Unfavorable Glasgow Outcome Scale (GOS)</title>
        <description>GOS measures the degree of disability associated with the brain injury
Unfavorable GOS included the categories of:
death.
vegetative status.
severe disability.</description>
        <time_frame>At hospital discharge, an average of 21 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>RBCT Based on rSO2 Value</title>
            <description>Intervention: In the rSO2 - strategy group, patients will be transfused to attain a post-transfusion rSO2 values higher than 60%.
Red blood cells transfusion: Patients will be transfused (one to one red blood cells unit transfusion)</description>
          </group>
          <group group_id="O2">
            <title>RBCT Based on Hemoglobin Level Value</title>
            <description>Intervention: In the hemoglobin – strategy group, patients will be transfused to reach post-transfusion hemoglobin levels between 8.5 g/dL and 10 g/dL.
Red blood cells transfusion: Patients will be transfused (one to one red blood cells unit transfusion)</description>
          </group>
        </group_list>
        <measure>
          <title>Unfavorable Glasgow Outcome Scale (GOS)</title>
          <description>GOS measures the degree of disability associated with the brain injury
Unfavorable GOS included the categories of:
death.
vegetative status.
severe disability.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="51"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27"/>
                    <measurement group_id="O2" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.22</p_value>
            <method>Chi-squared, Corrected</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>From admission of the patients into the protocol to the hospital discharge, an avarage 21 days</time_frame>
      <group_list>
        <group group_id="E1">
          <title>RBCT Based on rSO2 Value</title>
          <description>Intervention: In the rSO2 - strategy group, patients will be transfused to attain a post-transfusion rSO2 values higher than 60%.
Red blood cells transfusion: Patients will be transfused (one to one red blood cells unit transfusion)</description>
        </group>
        <group group_id="E2">
          <title>RBCT Based on Hemoglobin Level Value</title>
          <description>Intervention: In the hemoglobin – strategy group, patients will be transfused to reach post-transfusion hemoglobin levels between 8.5 g/dL and 10 g/dL.
Red blood cells transfusion: Patients will be transfused (one to one red blood cells unit transfusion)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Limited adherence to the protocol in the rSO2 arm</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Santiago R Leal-Noval, MD, PhD</name_or_title>
      <organization>University Hospital &quot;Virgen del Rocío&quot;</organization>
      <phone>0034954012528</phone>
      <email>srlealnoval@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

